Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Standard escalation follows: 0.25mg weeks 1-4, 0.5mg weeks 5-8, 1.0mg weeks 9-12, with potential further increases to 1.7mg or 2.4mg based on response
Its GLP-1 receptor agonist portfolio, anchored by semaglutide in its injectable form (Ozempic for diabetes, Wegovy for obesity) and oral form (Rybelsus), generated approximately USD 26 billion in combined sales in 2024, making semaglutide the world's highest-revenue drug
Melanotan II Injection pigmentation pathways
GLP-1 receptor agonists like semaglutide and tirzepatide experienced well-documented supply shortages as demand surged following widespread media coverage and consumer interest
US$ 21.75
US$ 21.65
US$ 23.21
US$ 27.51
